Pharmacokinetics of Enrofloxacin and Its Metabolite Ciprofloxacin after Intramuscular Administration of Enrofloxacin in Goats |
| |
Authors: | Rao G.S. Ramesh S. Ahmad A.H. Tripathi H.C. Sharma L.D. Malik J.K. |
| |
Affiliation: | (1) Division of Pharmacology and Toxicology, Indian Veterinary Research Institute, Izatnagar, 243 122 (U.P.), India;(2) Department of Pharmacology and Toxicology, College of Veterinary Sciences, GBPUA&T, Pantnagar, 263 145 (U.P.), India |
| |
Abstract: | The pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin were investigated in goats after a single intramuscular administration of enrofloxacin at 2.5 mg/kg body weight. The plasma concentrations of enrofloxacin and ciprofloxacin were determined simultaneously by a HPLC method. The peak concentrations (Cmax) of enrofloxacin (1.13 g/ml) and ciprofloxacin (0.24 g/ml) were observed at 0.8 and 1.2 h, respectively. The elimination half-life (t1/2 ), volume of distribution (Vd(area)), total body clearance (ClB) and mean residence time (MRT) of enrofloxacin were 0.74 h, 1.42 L/kg, 1329 ml/h per kg and 1.54 h, respectively. The t1/2 , area under the plasma concentration–time curve (AUC) and the MRT of ciprofloxacin were 1.38 h, 0.74 g h/ml and 2.73 h, respectively. The metabolic conversion of enrofloxacin to ciprofloxacin was appreciable (36%) and the sum of the plasma concentrations of enrofloxacin and ciprofloxacin was maintained at or above 0.1 g/ml for up to 4 h. Enrofloxacin appears to be useful for the treatment of goat diseases associated with pathogens sensitive to this drug. |
| |
Keywords: | ciprofloxacin dosage enrofloxacin goats pharmacokinetics plasma concentrations |
本文献已被 PubMed SpringerLink 等数据库收录! |
|